Rapid Medical (@rapid__medical) 's Twitter Profile
Rapid Medical

@rapid__medical

Pioneers of the only responsive interventional devices for ischemic & hemorrhagic stroke, enabling greater control over procedural outcomes.

ID: 1144308529320386560

linkhttp://Rapid-Medical.com calendar_today27-06-2019 18:16:28

797 Tweet

1,1K Takipçi

1,1K Takip Edilen

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

An intricate Y-90 case involving difficult access to a hepatic artery – Congratulations to Dr. Bulent Arslan, MD, FSIR from RUSH University Medical Center. This is an excellent showcase of DRIVEWIRE’s ability to fast-track procedures. 🏁 Thanks for sharing, Dr. Arslan.

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Acute angles can compromise clot integration. While self-expanding devices collapse around tight curves, TIGERTRIEVER™️ maintains radial force, preserving device integrity & shape, and maximizing clot integration at every angle. Review the data: rapid-medical-us.com/poster

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Dr. Michael Abraham navigates an intricate venous procedure using DRIVEWIRE 24, overcoming the challenges that traditional navigation with a standard wire often presents. Thanks for sharing, Dr. Abraham. Great case! 🏁 #DW24 #DRIVEWIRE #venous #navigation #neurovascular #stroke

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Prof. Sebastian Fischer emphasizes the critical need to consider a device like TIGERTRIEVER™ 13 for distal occlusions*, which account for 20-30% of stroke cases at Klinikum Siegen in Germany. “It is a big advantage that the device works with a very small microcatheter, so that

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Dr. Ryan Kellogg successfully navigates a complex arteriovenous fistula (AVF) in the transverse sinus, using DRIVEWIRE™’s on-demand tip articulation for faster vessel access. Set-up: Zoom 88 GC Access 25 MC Thank you for sharing, Dr. Kellogg 🏁

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

A big thank you to everyone we connected with at #LINNCParis! The past few days were truly inspiring, led by clinical discussions and live case coverage. It was a privilege to share our advanced #stroke technologies and to see so many of you at our booth experiencing the power of

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Newly published results with the TIGERTRIEVER 13 device for DMVO treatment show high recanalization and low bleeding rates.* #mechanicalthrombectomy #DISTALS *TIGERTRIEVER 13 is indicated for LVOs in the U.S. Off-label use is prohibited. Refer to Instructions for Use for more

Newly published results with the TIGERTRIEVER 13 device for DMVO treatment show high recanalization and low bleeding rates.* 

#mechanicalthrombectomy #DISTALS

*TIGERTRIEVER 13 is indicated for LVOs in the U.S. Off-label use is prohibited. Refer to Instructions for Use for more
Rapid Medical (@rapid__medical) 's Twitter Profile Photo

The latest sub-analysis of the DISTAL study showed the highest performing thrombectomy combination – stent retriever + aspiration outperformed either aspiration or stentriever alone. The Bilgin et. al meta-analysis showed the same in 2023, also presented at the DISTAL summit by

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

The “Dual Bite Pass,” pioneered by Dr. Daisuke Watanabe, combines TIGERTRIEVER™’s active technology with the suction of aspiration to enhance optimal clot integration and retrieval. 💡 Thanks for sharing, Dr. Watanabe.

The “Dual Bite Pass,” pioneered by Dr. Daisuke Watanabe, combines TIGERTRIEVER™’s active technology with the suction of aspiration to enhance optimal clot integration and retrieval. 💡 

Thanks for sharing, Dr. Watanabe.
Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Another publication shows TIGERTRIEVER™’s enhanced efficacy and safety compared to conventional self-expanding stent retrievers. 💡 Higher modified first-pass effect (71% vs. 53%, p = 0.02) 💡 Favorable safety profile: 0 perforations or dissections; numerically fewer

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

#SNIS2025 is headed to Music City—so are we! 🎸 Join Rapid Medical, Dr. David Altschul, and Dr. Erez Nossek on the rooftop of the Country Music Hall of Fame® and Museum for an exclusive DRIVEWIRE™ showcase—Nashville style. Tues. July 15 - 5:00 pm Register today:

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

When using aspiration, it’s important to consider effective methods that preserve intra-arterial safety at every step, such as utilizing a combination approach to keep the vessel patent during suction. Here are three different examples showing vessel collapse from aspiration,

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Should balloon guide catheters (BGCs) be used in distal medium vessel occlusions? According to a new retrospective analysis, the BGC group (n=73) had higher rates of FPE, higher rates of modified Rankin Scale (mRS) 0-­ 1, and lower rates of mortality at 90-­days compared with the

Should balloon guide catheters (BGCs) be used in distal medium vessel occlusions? According to a new retrospective analysis, the BGC group (n=73) had higher rates of FPE, higher rates of modified Rankin Scale (mRS) 0-­ 1, and lower rates of mortality at 90-­days compared with the
Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Attention: #SNIS2025 Attendees! 💡 Engage with our latest technological advancements in thrombectomy procedures, advanced endovascular navigation, and more. 🌐 Meet our Chief Technology Officer, US Leadership, and Product teams for a discussion of next-generation technologies

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

We’re revved up for #SNIS2025 🏁 Shift into high gear at booth #205 and experience DRIVEWIRE™ in action through NeuroJam – a high-speed, interactive challenge that puts next-gen navigation at your fingertips. #GameOn #SNIS SNIS Info #RapidMedical #DRIVEWIRE

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

We're grateful for an amazing week at #SNIS2025! 🎸 From hands-on discussions to impactful presentations, it was energizing to connect with so many dedicated neurointerventionalists throughout the week in Nashville. We would like to extend a heartfelt thanks to Drs. David

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

“It allows us to get to positions using less manipulation of the vessels and tools." See how Dr. Geoffrey Colby leverages DRIVEWIRE™ to accelerate access, facilitate navigation, and enhance patient safety across interventional procedures. Reshape. Navigate. Deliver.

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

Treatment of distal vessel occlusions (DMVO) is rapidly evolving — and device selection is critical, especially in delicate anatomy. With new data emerging and the differentiated DISTALS Study ongoing, now’s the time to dive in. Join us for a live webinar on August 26th.

Treatment of distal vessel occlusions (DMVO) is rapidly evolving — and device selection is critical, especially in delicate anatomy. With new data emerging and the differentiated DISTALS Study ongoing, now’s the time to dive in. Join us for a live webinar on August 26th.
Rapid Medical (@rapid__medical) 's Twitter Profile Photo

A challenging DAVF case by Dr. Sri Hari Sundararajan. Following initial access attempts with Synchro Select™ guidewire, DRIVEWIRE™’s real-time tip deflection enabled fast, precise navigation and smooth advancement of the AXS Catalyst™ 5 distal access catheter. Thanks for

Rapid Medical (@rapid__medical) 's Twitter Profile Photo

As emphasized by Dr. Rishi Gupta in Endovascular Today, the #DISTALSstudy is ongoing and evaluates mechanical thrombectomy for MeVOs (Medium Vessel Occlusions) using devices specifically designed for smaller vessels in patients who didn’t receive IV thrombolytics. Why it matters: 🔎 MeVOs

As emphasized by Dr. Rishi Gupta in <a href="/EVToday/">Endovascular Today</a>, the #DISTALSstudy is ongoing and evaluates mechanical thrombectomy for MeVOs (Medium Vessel Occlusions) using devices specifically designed for smaller vessels in patients who didn’t receive IV thrombolytics.

Why it matters:
🔎 MeVOs